| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |